Allspring Global Investments Holdings LLC Sells 111,017 Shares of Maximus, Inc. $MMS

Allspring Global Investments Holdings LLC cut its position in Maximus, Inc. (NYSE:MMS) by 21.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 415,876 shares of the health services provider’s stock after selling 111,017 shares during the period. Allspring Global Investments Holdings LLC owned 0.76% of Maximus worth $35,961,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MMS. Arizona State Retirement System lifted its holdings in shares of Maximus by 0.9% in the 3rd quarter. Arizona State Retirement System now owns 16,674 shares of the health services provider’s stock worth $1,524,000 after purchasing an additional 156 shares in the last quarter. GAMMA Investing LLC boosted its stake in Maximus by 13.9% during the 3rd quarter. GAMMA Investing LLC now owns 1,337 shares of the health services provider’s stock valued at $122,000 after purchasing an additional 163 shares during the last quarter. Trust Point Inc. increased its holdings in Maximus by 3.7% during the 3rd quarter. Trust Point Inc. now owns 5,286 shares of the health services provider’s stock worth $483,000 after purchasing an additional 191 shares in the last quarter. Richardson Financial Services Inc. increased its holdings in Maximus by 123.1% during the 3rd quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock worth $32,000 after purchasing an additional 192 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Maximus by 0.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after purchasing an additional 221 shares during the last quarter. 97.21% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on MMS shares. Weiss Ratings lowered Maximus from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, February 24th. Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Finally, Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Maximus has a consensus rating of “Buy”.

Insiders Place Their Bets

In other Maximus news, CFO David Mutryn bought 1,000 shares of the business’s stock in a transaction on Monday, February 9th. The stock was purchased at an average price of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the transaction, the chief financial officer directly owned 40,037 shares of the company’s stock, valued at $3,027,597.94. This trade represents a 2.56% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Bruce Caswell bought 3,175 shares of Maximus stock in a transaction dated Tuesday, February 10th. The stock was acquired at an average price of $78.45 per share, with a total value of $249,078.75. Following the purchase, the chief executive officer directly owned 328,013 shares of the company’s stock, valued at approximately $25,732,619.85. This represents a 0.98% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 1.80% of the company’s stock.

Maximus Stock Down 0.4%

MMS opened at $62.32 on Friday. The company’s 50-day moving average price is $76.48 and its two-hundred day moving average price is $83.63. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a twelve month low of $60.75 and a twelve month high of $100.00. The stock has a market cap of $3.40 billion, a price-to-earnings ratio of 9.49 and a beta of 0.63.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The company had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.37 billion. During the same quarter in the previous year, the firm posted $1.61 EPS. Maximus’s revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 2.1%. This is a boost from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, February 13th. Maximus’s payout ratio is currently 20.09%.

Maximus Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.